GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cresco Labs Inc (XCNQ:CL) » Definitions » Change In Receivables

Cresco Labs (XCNQ:CL) Change In Receivables : C$-7 Mil (TTM As of Dec. 2023)


View and export this data going back to 1991. Start your Free Trial

What is Cresco Labs Change In Receivables?

Cresco Labs's change in receivables for the quarter that ended in Dec. 2023 was C$5 Mil. It means Cresco Labs's Accounts Receivable declined by C$5 Mil from Sep. 2023 to Dec. 2023 .

Cresco Labs's change in receivables for the fiscal year that ended in Dec. 2023 was C$-7 Mil. It means Cresco Labs's Accounts Receivable increased by C$7 Mil from Dec. 2022 to Dec. 2023 .

Cresco Labs's Accounts Receivable for the quarter that ended in Dec. 2023 was C$69 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Cresco Labs's Days Sales Outstanding for the three months ended in Dec. 2023 was 24.76.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Cresco Labs's liquidation value for the three months ended in Dec. 2023 was C$-986 Mil.


Cresco Labs Change In Receivables Historical Data

The historical data trend for Cresco Labs's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cresco Labs Change In Receivables Chart

Cresco Labs Annual Data
Trend Jan14 Jan15 Jan16 Jan17 Jan18 Dec19 Dec20 Dec21 Dec22 Dec23
Change In Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only -16.83 -8.46 -14.03 -20.07 -7.20

Cresco Labs Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -6.89 5.22 -13.97 -2.89 4.64

Cresco Labs Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-7 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cresco Labs  (XCNQ:CL) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Cresco Labs's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=68.516/252.539*91
=24.76

2. In Ben Graham's calculation of liquidation value, Cresco Labs's accounts receivable are only considered to be worth 75% of book value:

Cresco Labs's liquidation value for the quarter that ended in Dec. 2023 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=138.76-1248.225+0.75 * 68.516+0.5 * 144.61
=-986

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cresco Labs Change In Receivables Related Terms

Thank you for viewing the detailed overview of Cresco Labs's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Cresco Labs (XCNQ:CL) Business Description

Traded in Other Exchanges
Address
400 W. Erie Street, Suite 110, Chicago, IL, USA, 60654
Cresco Labs Inc is a vertically-integrated multi-state cannabis operator in the United States licensed to cultivate, manufacture and sell retail and medical cannabis products through Sunnyside, Cresco Labs' national dispensary brand and third-party retail stores. The Company operates in one segment, the cultivation, manufacturing, distribution and sale of cannabis.